[go: up one dir, main page]

DE4039060A1 - Neue kristallform - Google Patents

Neue kristallform

Info

Publication number
DE4039060A1
DE4039060A1 DE4039060A DE4039060A DE4039060A1 DE 4039060 A1 DE4039060 A1 DE 4039060A1 DE 4039060 A DE4039060 A DE 4039060A DE 4039060 A DE4039060 A DE 4039060A DE 4039060 A1 DE4039060 A1 DE 4039060A1
Authority
DE
Germany
Prior art keywords
methyl
cyclohexyl
adenosine
hydrate
etherate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4039060A
Other languages
German (de)
English (en)
Inventor
Fulvio Dr Gadient
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Priority to DE4039060A priority Critical patent/DE4039060A1/de
Priority to HU913662A priority patent/HUT61567A/hu
Priority to CA002056967A priority patent/CA2056967A1/en
Priority to NZ240873A priority patent/NZ240873A/xx
Priority to NO914779A priority patent/NO178545C/no
Priority to PT99690A priority patent/PT99690B/pt
Priority to EP91810942A priority patent/EP0490818B1/en
Priority to EP96120163A priority patent/EP0774259A1/en
Priority to AU88887/91A priority patent/AU647216B2/en
Priority to SG1996009727A priority patent/SG44937A1/en
Priority to IL10024191A priority patent/IL100241A/en
Priority to DE69127350T priority patent/DE69127350D1/de
Priority to AT91810942T priority patent/ATE157007T1/de
Priority to FI915734A priority patent/FI915734L/fi
Priority to PL91292665A priority patent/PL166094B1/pl
Priority to JP3322985A priority patent/JPH04290895A/ja
Priority to IE424891A priority patent/IE914248A1/en
Priority to KR1019910022284A priority patent/KR920011494A/ko
Priority to ZA919658A priority patent/ZA919658B/xx
Priority to TW080109606A priority patent/TW224050B/zh
Publication of DE4039060A1 publication Critical patent/DE4039060A1/de
Priority to NO954076A priority patent/NO954076D0/no
Priority to JP8216309A priority patent/JPH09110700A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE4039060A 1990-12-07 1990-12-07 Neue kristallform Withdrawn DE4039060A1 (de)

Priority Applications (22)

Application Number Priority Date Filing Date Title
DE4039060A DE4039060A1 (de) 1990-12-07 1990-12-07 Neue kristallform
HU913662A HUT61567A (en) 1990-12-07 1991-11-25 Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
CA002056967A CA2056967A1 (en) 1990-12-07 1991-12-04 Use of organic compounds
DE69127350T DE69127350D1 (de) 1990-12-07 1991-12-05 6-cyclohexyl-2'-0-methyl-adenosine hydrat und verwendungengen davon
NO914779A NO178545C (no) 1990-12-07 1991-12-05 Fremgangsmåte for fremstilling av en adenosinforbindelse i ny krystallform
PT99690A PT99690B (pt) 1990-12-07 1991-12-05 Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina
EP91810942A EP0490818B1 (en) 1990-12-07 1991-12-05 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof
EP96120163A EP0774259A1 (en) 1990-12-07 1991-12-05 New use of organic compounds
AU88887/91A AU647216B2 (en) 1990-12-07 1991-12-05 Improvements in or relating to organic compounds
SG1996009727A SG44937A1 (en) 1990-12-07 1991-12-05 New use of organic compounds
IL10024191A IL100241A (en) 1990-12-07 1991-12-05 6-Cyclohexyl- (2-0-methyl adenosine hydrate, its preparation and pharmaceutical preparations containing the same
NZ240873A NZ240873A (en) 1990-12-07 1991-12-05 6-cyclohexyl-2'-o-methyl-adenosine hydrate preparation and pharmaceutical compositions thereof
AT91810942T ATE157007T1 (de) 1990-12-07 1991-12-05 6-cyclohexyl-2'-0-methyl-adenosine hydrat und verwendungengen davon
FI915734A FI915734L (fi) 1990-12-07 1991-12-05 Foerfarande foer framstaellning av 6-cykloheksyl-2'0-metyladenosin.
PL91292665A PL166094B1 (pl) 1990-12-07 1991-12-06 Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL
JP3322985A JPH04290895A (ja) 1990-12-07 1991-12-06 有機化合物の新用途
IE424891A IE914248A1 (en) 1990-12-07 1991-12-06 New use of organic compounds
KR1019910022284A KR920011494A (ko) 1990-12-07 1991-12-06 2'-o-알킬-아데노신 유도체의 사용방법
ZA919658A ZA919658B (en) 1990-12-07 1991-12-06 New use of organic compounds.
TW080109606A TW224050B (fi) 1990-12-07 1991-12-07
NO954076A NO954076D0 (no) 1990-12-07 1995-10-13 Fremgangsmåte for fremstilling av en krystallform og et farmasöytisk preparat derav
JP8216309A JPH09110700A (ja) 1990-12-07 1996-08-16 医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039060A DE4039060A1 (de) 1990-12-07 1990-12-07 Neue kristallform

Publications (1)

Publication Number Publication Date
DE4039060A1 true DE4039060A1 (de) 1992-06-11

Family

ID=6419797

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4039060A Withdrawn DE4039060A1 (de) 1990-12-07 1990-12-07 Neue kristallform

Country Status (9)

Country Link
DE (1) DE4039060A1 (fi)
FI (1) FI915734L (fi)
IL (1) IL100241A (fi)
NO (1) NO178545C (fi)
NZ (1) NZ240873A (fi)
PL (1) PL166094B1 (fi)
SG (1) SG44937A1 (fi)
TW (1) TW224050B (fi)
ZA (1) ZA919658B (fi)

Also Published As

Publication number Publication date
NZ240873A (en) 1993-09-27
PL292665A1 (en) 1992-12-14
FI915734A0 (fi) 1991-12-05
TW224050B (fi) 1994-05-21
FI915734L (fi) 1992-06-08
PL166094B1 (pl) 1995-03-31
NO178545B (no) 1996-01-08
NO914779D0 (no) 1991-12-05
SG44937A1 (en) 1997-12-19
IL100241A0 (en) 1992-09-06
NO178545C (no) 1996-04-17
IL100241A (en) 1995-12-08
NO914779L (no) 1992-06-09
ZA919658B (en) 1993-06-27

Similar Documents

Publication Publication Date Title
EP0043535B1 (de) Tricyclische Arylether, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE68929455T2 (de) Thieno 3,2-f 1,2,4 triazolo 4,3-a 1,4 diazepinderivate als PAF-Antagonisten
DE69130869T2 (de) Xanthinderivate
DE2742435A1 (de) Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
DE2819094A1 (de) Cyclosporin-derivate, ihre verwendung und herstellung
EP0387821B1 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
DE1917874C3 (de) 14-Halogendaunomycine, Verfahren zu ihrer Herstellung und deren Verwendung zur Herstellung von Adriamycin
DE69014064T2 (de) Benzopyranon-beta-D-thioxyloside, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
EP0044989A1 (de) Neue, in 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo (b,e)(1,4)diazepin-11-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3223587A (en) Cardiac active acyl cymarols
Gupta et al. Withanolides of Datura metel
DE4039060A1 (de) Neue kristallform
DE2733867C3 (de) Oleandomycinderivate und diese Verbindungen enthaltende antibakterielle Mittel
EP0064255A1 (de) Benzopyranylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel und Zwischenprodukte
DE68928127T2 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
DE2426682A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2852606A1 (de) 3-di-n-propyl-acetoxy-benzodiazepin-2-one und verfahren zu deren herstellung
DE1903901A1 (de) Neue Cardenolid-amino-desoxyglycoside
DE68920304T2 (de) 5-substituierte uridinderivate und zwischenprodukte.
CH650006A5 (en) Process for the preparation of 5-fluorouracil derivatives
DE2122209A1 (de) Neue durch einen Steroidrest substituierte Derivate des Acrylnitrils und Verfahren zu ihrer Herstellung
EP0066467A1 (en) 11-Alpha-amino-androstanes
DE3128277A1 (de) (omega)-(5-(1-imidazolylmethyl)-thien-2-y1)-alkancarbonsaeuren und deren derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3874291T2 (de) Reines kristallines methyl-2-acryl-amino-2-methoxy-acetat und verfahren zu dessen herstellung.
AT227875B (de) Verfahren zur katalytischen Reduktion von Tetracyclinverbindungen

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: NOVARTIS AG, BASEL, CH

8128 New person/name/address of the agent

Representative=s name: SPOTT WEINMILLER & PARTNER, 80336 MUENCHEN

8141 Disposal/no request for examination